Klinicist (May 2015)
EFFICACY AND SAFETY OF 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS
- M. S. Naumtseva,
- B. S. Belov,
- G. M. Tarasova,
- D. E. Karateev,
- E. L. Luchikhina,
- Yu. V. Muravyev,
- E. N. Aleksandrova,
- A. A. Novikov
Affiliations
- M. S. Naumtseva
- V.A. Nasonova Research Institute of Rheumatology; 34А Kashirskoe Shosse, Moscow, 115522, Russia
- B. S. Belov
- V.A. Nasonova Research Institute of Rheumatology; 34А Kashirskoe Shosse, Moscow, 115522, Russia
- G. M. Tarasova
- V.A. Nasonova Research Institute of Rheumatology; 34А Kashirskoe Shosse, Moscow, 115522, Russia
- D. E. Karateev
- V.A. Nasonova Research Institute of Rheumatology; 34А Kashirskoe Shosse, Moscow, 115522, Russia
- E. L. Luchikhina
- V.A. Nasonova Research Institute of Rheumatology; 34А Kashirskoe Shosse, Moscow, 115522, Russia
- Yu. V. Muravyev
- V.A. Nasonova Research Institute of Rheumatology; 34А Kashirskoe Shosse, Moscow, 115522, Russia
- E. N. Aleksandrova
- V.A. Nasonova Research Institute of Rheumatology; 34А Kashirskoe Shosse, Moscow, 115522, Russia
- A. A. Novikov
- V.A. Nasonova Research Institute of Rheumatology; 34А Kashirskoe Shosse, Moscow, 115522, Russia
- DOI
- https://doi.org/10.17650/1818-8338-2015-1-60-63
- Journal volume & issue
-
Vol. 9,
no. 1
pp. 60 – 63
Abstract
No abstracts available.Keywords
- rheumatoid arthritis
- autoimmune diseases
- comorbid infections
- comorbidity
- pneumonia
- bronchitis
- pneumococcal vaccine
- vaccination
- immunogenicity
- efficacy
- tolerability
